Integer Holdings ITGR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Sales by Product | |||||
| Cardiac Rhythm Management & Neuromodulation | $668.8M+1.2% | $660.61M+7.8% | $612.89M+14.7% | $534.37M+6.4% | |
| Other Markets | $77.75M-26.9% | $106.41M0.0% | $106.42M+9.1% | $97.51M— | |
| Sales by Geography | |||||
| Costa Rica | $173.52M+39.2% | $124.69M+15.0% | $108.42M+42.4% | $76.14M+13.7% | |
| Ireland | $99.16M+17.5% | $84.41M+22.2% | $69.09M— | —— | |
| Puerto Rico | $131.26M-4.2% | $137.06M+12.8% | $121.49M+6.5% | $114.08M+3.6% | |
| Rest of world | $469.89M+8.8% | $431.76M+12.5% | $383.73M-6.1% | $408.46M+9.7% | |
| U.S. | $979.81M+4.4% | $938.68M+7.5% | $872.93M+19.2% | $732.6M+9.1% | |
| Long-Lived Assets by Geography | |||||
| Ireland | $623.46M— | —— | —— | —— | |
| Mexico | $169.07M— | —— | —— | —— | |
| Rest of world | $123.5M— | —— | —— | —— | |
| United States | $1.15B— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
